1. Progress with humanized antibodied - an update;Adair;Exp. Opin. Invest. Drugs,1995
2. Effect of a single amino acid mutation on the activating and immonosuppressive properties of a “humanized” OKT3 monoclonal antibody;Alegre;J. Immunol.,1992
3. Long-circulating (sterically stabilized) liposomes for targeted drug delivery;Allen;Trends Pharmacol. Sci.,1994
4. Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor;Anasetti;Blood,1994